TY - JOUR T1 - Violin plot data: A concerto of crucial information on valve thrombogenicity classified using laboratory measured valve motion JF - medRxiv DO - 10.1101/19009407 SP - 19009407 AU - Lawrence N. Scotten AU - David J. Blundon AU - Marcus-André Deutsch AU - Rolland Siegel Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/26/19009407.abstract N2 - Background A thrombogenic potential metric was used to compare prosthetic valve models in vitro.Methods Valves were tested in aortic and mitral sites under pulsatile circulation in a pulse duplicator. An optical approach measures dynamic valve area. Pulsatile fluid dynamics were measured by conventional techniques and a quasi-steady flow tester was used to measure valve leakage. Regurgitant flow velocity was derived using time-dependent volumetric flow rate / dynamic valve area. Since flow velocity and fluid shear force are related through flow velocity gradient, thrombogenic potential for valves that achieve near closure during the forward flow deceleration phase were determined as regurgitant flow velocities relative to the control mechanical valve regurgitant flow velocity of −126 m/s. Analysis of the flow velocity data made use of Vioplot R* and VISIO software packages to provide split violin plots that represent probability of recurrence of data.Results Thrombogenic potential was made dimensionless and ranged between −0.45 and +1.0. Negative thrombogenic potentials arise when transient rebound of valve occluder is accompanied by water-hammer phenomena. Positive thrombogenic potentials occur during decelerating forward flow. Bioprostheses had lowest thrombogenic potential transient of 0.15. A mock-transcatheter aortic valve replacement incorporating by design a trivial paravalvular leak (∼1.35 ml/s) demonstrated a high transient thrombogenic potential of 0.95.Conclusions Our data reveals distinct thrombogenic potential profile differences between valve models. If our study methods are verifiable, the design of future valves may utilize currently available experimental tools to produce advanced devices with significantly reduced thrombogenic potential.Highlights➢ Prosthetic valve shortcomings include chronic unresolved thrombogenicity and durability issues.➢ Thrombogenic potential of mechanical valves is fueled by brief, high closing flow velocities.➢ Trivial leakage in bioprosthetic valves can yield high thrombogenic potential.➢ Valve motion and flow velocity metrics may help advance prosthetic valve designs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research has been done on a pro bono basis by all authors with no financial support of others.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableAll data relevant to the study are included in the article or uploaded as supplementary information.BHVbioprosthetic heart valveBV3Drapid prototype bileaflet mechanical valve (3D printed)HITShigh intensity trancranial signalml/smilliliters per secondm/smeters per secondmsmillisecondsmTAVRmock-transcatheter aortic valve replacementMHVmechanical heart valvePDVAprojected dynamic valve areaPVLparavalvular leakageRFVregurgitant flow velocityssecondSJMSt Jude MedicalTPthrombogenic potentialVIAviscoelastic impedance adapter ER -